APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Medicines and Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Veterinary Medicines and Vaccines Market Analysis and Forecast 2026-2032

Report ID 17404619022 January 2026198 pages

Choose your research edition.

Industry ResearchVeterinary Medicines and Vaccines Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Medicines and Vaccines Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Veterinary Medicines and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Medicines and Vaccines Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Medicines and Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Veterinary Medicines and Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Veterinary Medicines and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Veterinary Medicines and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Veterinary Medicines and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Veterinary Medicines and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Veterinary Medicines and Vaccines include Boehringer Ingelheim, Ceva, Dechra Veterinary Products, Elanco Animal Health, Meiji, Ouro Fino Saude, Parnell, Vetoquinol and Virbac, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Veterinary Medicines and Vaccines, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Veterinary Medicines and Vaccines, also provides the revenue of main regions and countries. Of the upcoming market potential for Veterinary Medicines and Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Veterinary Medicines and Vaccines revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Veterinary Medicines and Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Veterinary Medicines and Vaccines revenue, projected growth trends, production technology, application and end-user industry.

Veterinary Medicines and Vaccines Segment by Company

Boehringer Ingelheim

Ceva

Dechra Veterinary Products

Elanco Animal Health

Meiji

Ouro Fino Saude

Parnell

Vetoquinol

Virbac

Zoetis

Bayer Animal Health

Merck Animal Health

Veterinary Medicines and Vaccines Segment by Type

Medicines

Vaccines

Veterinary Medicines and Vaccines Segment by Application

Companion Animals

Farm Animals

Veterinary Medicines and Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Medicines and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Medicines and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Medicines and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Veterinary Medicines and Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Veterinary Medicines and Vaccines company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Medicines and Vaccines revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Veterinary Medicines and Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Medicines Major Player Table 3. Vaccines Major Player Table 4. Global Veterinary Medicines and Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Companion Animals Major Player Table 6. Farm Animals Major Player Table 7. Veterinary Medicines and Vaccines Industry Trends Table 8. Veterinary Medicines and Vaccines Industry Drivers Table 9. Veterinary Medicines and Vaccines Industry Opportunities and Challenges Table 10. Veterinary Medicines and Vaccines Industry Restraints Table 11. Global Veterinary Medicines and Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Veterinary Medicines and Vaccines Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Veterinary Medicines and Vaccines Market Share by Region (2021-2026) Table 14. Global Veterinary Medicines and Vaccines Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Veterinary Medicines and Vaccines Market Share by Region (2027-2032) Table 16. Global Veterinary Medicines and Vaccines Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Veterinary Medicines and Vaccines Revenue Market Share by Players (2021-2026) Table 18. Global Veterinary Medicines and Vaccines Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Veterinary Medicines and Vaccines Key Players Headquarters & Area Served Table 20. Global Veterinary Medicines and Vaccines Players, Product Type & Application Table 21. Global Veterinary Medicines and Vaccines Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Veterinary Medicines and Vaccines by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Veterinary Medicines and Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Veterinary Medicines and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Veterinary Medicines and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Veterinary Medicines and Vaccines Revenue Market Share by Type (2021-2026) Table 28. Global Veterinary Medicines and Vaccines Revenue Market Share by Type (2027-2032) Table 29. Global Veterinary Medicines and Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Veterinary Medicines and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Veterinary Medicines and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Veterinary Medicines and Vaccines Revenue Market Share by Application (2021-2026) Table 33. Global Veterinary Medicines and Vaccines Revenue Market Share by Application (2027-2032) Table 34. Boehringer Ingelheim Company Information Table 35. Boehringer Ingelheim Business Overview Table 36. Boehringer Ingelheim Veterinary Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Boehringer Ingelheim Veterinary Medicines and Vaccines Product Portfolio Table 38. Boehringer Ingelheim Recent Development Table 39. Ceva Company Information Table 40. Ceva Business Overview Table 41. Ceva Veterinary Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Ceva Veterinary Medicines and Vaccines Product Portfolio Table 43. Ceva Recent Development Table 44. Dechra Veterinary Products Company Information Table 45. Dechra Veterinary Products Business Overview Table 46. Dechra Veterinary Products Veterinary Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Dechra Veterinary Products Veterinary Medicines and Vaccines Product Portfolio Table 48. Dechra Veterinary Products Recent Development Table 49. Elanco Animal Health Company Information Table 50. Elanco Animal Health Business Overview Table 51. Elanco Animal Health Veterinary Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Elanco Animal Health Veterinary Medicines and Vaccines Product Portfolio Table 53. Elanco Animal Health Recent Development Table 54. Meiji Company Information Table 55. Meiji Business Overview Table 56. Meiji Veterinary Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Meiji Veterinary Medicines and Vaccines Product Portfolio Table 58. Meiji Recent Development Table 59. Ouro Fino Saude Company Information Table 60. Ouro Fino Saude Business Overview Table 61. Ouro Fino Saude Veterinary Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Ouro Fino Saude Veterinary Medicines and Vaccines Product Portfolio Table 63. Ouro Fino Saude Recent Development Table 64. Parnell Company Information Table 65. Parnell Business Overview Table 66. Parnell Veterinary Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Parnell Veterinary Medicines and Vaccines Product Portfolio Table 68. Parnell Recent Development Table 69. Vetoquinol Company Information Table 70. Vetoquinol Business Overview Table 71. Vetoquinol Veterinary Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Vetoquinol Veterinary Medicines and Vaccines Product Portfolio Table 73. Vetoquinol Recent Development Table 74. Virbac Company Information Table 75. Virbac Business Overview Table 76. Virbac Veterinary Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Virbac Veterinary Medicines and Vaccines Product Portfolio Table 78. Virbac Recent Development Table 79. Zoetis Company Information Table 80. Zoetis Business Overview Table 81. Zoetis Veterinary Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Zoetis Veterinary Medicines and Vaccines Product Portfolio Table 83. Zoetis Recent Development Table 84. Bayer Animal Health Company Information Table 85. Bayer Animal Health Business Overview Table 86. Bayer Animal Health Veterinary Medicines and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Bayer Animal Health Veterinary Medicines and Vaccines Product Portfolio Table 88. Bayer Animal Health Recent Development Table 89. Merck Animal Health Company Information Table 90. Merck Animal Health Business Overview Table 91. Merck Animal Health Veterinary Medicines and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Merck Animal Health Veterinary Medicines and Vaccines Product Portfolio Table 93. Merck Animal Health Recent Development Table 94. North America Veterinary Medicines and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 95. North America Veterinary Medicines and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 96. North America Veterinary Medicines and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 97. North America Veterinary Medicines and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 98. North America Veterinary Medicines and Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America Veterinary Medicines and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 100. North America Veterinary Medicines and Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 101. Europe Veterinary Medicines and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 102. Europe Veterinary Medicines and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 103. Europe Veterinary Medicines and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 104. Europe Veterinary Medicines and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 105. Europe Veterinary Medicines and Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. Europe Veterinary Medicines and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 107. Europe Veterinary Medicines and Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 108. China Veterinary Medicines and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 109. China Veterinary Medicines and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 110. China Veterinary Medicines and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 111. China Veterinary Medicines and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 112. Asia Veterinary Medicines and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 113. Asia Veterinary Medicines and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 114. Asia Veterinary Medicines and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 115. Asia Veterinary Medicines and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 116. Asia Veterinary Medicines and Vaccines Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Asia Veterinary Medicines and Vaccines Revenue by Region (US$ Million) & (2021-2026) Table 118. Asia Veterinary Medicines and Vaccines Revenue by Region (US$ Million) & (2027-2032) Table 119. SAMEA Veterinary Medicines and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 120. SAMEA Veterinary Medicines and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 121. SAMEA Veterinary Medicines and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 122. SAMEA Veterinary Medicines and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 123. SAMEA Veterinary Medicines and Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. SAMEA Veterinary Medicines and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 125. SAMEA Veterinary Medicines and Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Veterinary Medicines and Vaccines Image Figure 2. Global Veterinary Medicines and Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Medicines and Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Medicines Image Figure 5. Vaccines Image Figure 6. Global Veterinary Medicines and Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Veterinary Medicines and Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Companion Animals Image Figure 9. Farm Animals Image Figure 10. Global Veterinary Medicines and Vaccines Market Size (US$ Million) & (2021-2032) Figure 11. Global Veterinary Medicines and Vaccines Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Veterinary Medicines and Vaccines Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Veterinary Medicines and Vaccines Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Veterinary Medicines and Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Veterinary Medicines and Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Veterinary Medicines and Vaccines Revenue Market Share by Type (2021-2032) Figure 18. Global Veterinary Medicines and Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Veterinary Medicines and Vaccines Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Veterinary Medicines and Vaccines Revenue Market Share by Application (2021-2032) Figure 21. North America Veterinary Medicines and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Veterinary Medicines and Vaccines Revenue Share by Type (2021-2032) Figure 23. North America Veterinary Medicines and Vaccines Revenue Share by Application (2021-2032) Figure 24. North America Veterinary Medicines and Vaccines Revenue Share by Country (2021-2032) Figure 25. United States Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Veterinary Medicines and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Veterinary Medicines and Vaccines Revenue Share by Type (2021-2032) Figure 30. Europe Veterinary Medicines and Vaccines Revenue Share by Application (2021-2032) Figure 31. Europe Veterinary Medicines and Vaccines Revenue Share by Country (2021-2032) Figure 32. Germany Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Veterinary Medicines and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Veterinary Medicines and Vaccines Revenue Share by Type (2021-2032) Figure 42. China Veterinary Medicines and Vaccines Revenue Share by Application (2021-2032) Figure 43. Asia Veterinary Medicines and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Veterinary Medicines and Vaccines Revenue Share by Type (2021-2032) Figure 45. Asia Veterinary Medicines and Vaccines Revenue Share by Application (2021-2032) Figure 46. Asia Veterinary Medicines and Vaccines Revenue Share by Region (2021-2032) Figure 47. Japan Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Veterinary Medicines and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Veterinary Medicines and Vaccines Revenue Share by Type (2021-2032) Figure 55. SAMEA Veterinary Medicines and Vaccines Revenue Share by Application (2021-2032) Figure 56. SAMEA Veterinary Medicines and Vaccines Revenue Share by Country (2021-2032) Figure 57. Brazil Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Veterinary Medicines and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Medicines
  • Vaccines
Applications
  • Companion Animals
  • Farm Animals
Companies covered
  • Boehringer Ingelheim
  • Ceva
  • Dechra Veterinary Products
  • Elanco Animal Health
  • Meiji
  • Ouro Fino Saude
  • Parnell
  • Vetoquinol
  • Virbac
  • Zoetis
  • Bayer Animal Health
  • Merck Animal Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Veterinary Medicines and Vaccines Market by Type
  3. 1.2.1 Global Veterinary Medicines and Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Medicines
  5. 1.2.3 Vaccines
  6. 1.3 Veterinary Medicines and Vaccines Market by Application
  7. 1.3.1 Global Veterinary Medicines and Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Companion Animals
  9. 1.3.3 Farm Animals
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Veterinary Medicines and Vaccines Market Dynamics
  1. 2.1 Veterinary Medicines and Vaccines Industry Trends
  2. 2.2 Veterinary Medicines and Vaccines Industry Drivers
  3. 2.3 Veterinary Medicines and Vaccines Industry Opportunities and Challenges
  4. 2.4 Veterinary Medicines and Vaccines Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Veterinary Medicines and Vaccines Market Perspective (2021-2032)
  2. 3.2 Global Veterinary Medicines and Vaccines Growth Trends by Region
  3. 3.2.1 Global Veterinary Medicines and Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Veterinary Medicines and Vaccines Market Size by Region (2021-2026)
  5. 3.2.3 Global Veterinary Medicines and Vaccines Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Veterinary Medicines and Vaccines Revenue by Players
  2. 4.1.1 Global Veterinary Medicines and Vaccines Revenue by Players (2021-2026)
  3. 4.1.2 Global Veterinary Medicines and Vaccines Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Veterinary Medicines and Vaccines Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Veterinary Medicines and Vaccines Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Veterinary Medicines and Vaccines Key Players Headquarters & Area Served
  7. 4.4 Global Veterinary Medicines and Vaccines Players, Product Type & Application
  8. 4.5 Global Veterinary Medicines and Vaccines Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Veterinary Medicines and Vaccines Market CR5 and HHI
  11. 4.6.3 2025 Veterinary Medicines and Vaccines Tier 1, Tier 2, and Tier 3
5 Veterinary Medicines and Vaccines Market Size by Type
  1. 5.1 Global Veterinary Medicines and Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Veterinary Medicines and Vaccines Revenue by Type (2021-2032)
  3. 5.3 Global Veterinary Medicines and Vaccines Revenue Market Share by Type (2021-2032)
6 Veterinary Medicines and Vaccines Market Size by Application
  1. 6.1 Global Veterinary Medicines and Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Veterinary Medicines and Vaccines Revenue by Application (2021-2032)
  3. 6.3 Global Veterinary Medicines and Vaccines Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Boehringer Ingelheim
  2. 7.1.1 Boehringer Ingelheim Company Information
  3. 7.1.2 Boehringer Ingelheim Business Overview
  4. 7.1.3 Boehringer Ingelheim Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Boehringer Ingelheim Veterinary Medicines and Vaccines Product Portfolio
  6. 7.1.5 Boehringer Ingelheim Recent Developments
  7. 7.2 Ceva
  8. 7.2.1 Ceva Company Information
  9. 7.2.2 Ceva Business Overview
  10. 7.2.3 Ceva Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Ceva Veterinary Medicines and Vaccines Product Portfolio
  12. 7.2.5 Ceva Recent Developments
  13. 7.3 Dechra Veterinary Products
  14. 7.3.1 Dechra Veterinary Products Company Information
  15. 7.3.2 Dechra Veterinary Products Business Overview
  16. 7.3.3 Dechra Veterinary Products Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Dechra Veterinary Products Veterinary Medicines and Vaccines Product Portfolio
  18. 7.3.5 Dechra Veterinary Products Recent Developments
  19. 7.4 Elanco Animal Health
  20. 7.4.1 Elanco Animal Health Company Information
  21. 7.4.2 Elanco Animal Health Business Overview
  22. 7.4.3 Elanco Animal Health Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Elanco Animal Health Veterinary Medicines and Vaccines Product Portfolio
  24. 7.4.5 Elanco Animal Health Recent Developments
  25. 7.5 Meiji
  26. 7.5.1 Meiji Company Information
  27. 7.5.2 Meiji Business Overview
  28. 7.5.3 Meiji Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Meiji Veterinary Medicines and Vaccines Product Portfolio
  30. 7.5.5 Meiji Recent Developments
  31. 7.6 Ouro Fino Saude
  32. 7.6.1 Ouro Fino Saude Company Information
  33. 7.6.2 Ouro Fino Saude Business Overview
  34. 7.6.3 Ouro Fino Saude Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Ouro Fino Saude Veterinary Medicines and Vaccines Product Portfolio
  36. 7.6.5 Ouro Fino Saude Recent Developments
  37. 7.7 Parnell
  38. 7.7.1 Parnell Company Information
  39. 7.7.2 Parnell Business Overview
  40. 7.7.3 Parnell Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Parnell Veterinary Medicines and Vaccines Product Portfolio
  42. 7.7.5 Parnell Recent Developments
  43. 7.8 Vetoquinol
  44. 7.8.1 Vetoquinol Company Information
  45. 7.8.2 Vetoquinol Business Overview
  46. 7.8.3 Vetoquinol Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Vetoquinol Veterinary Medicines and Vaccines Product Portfolio
  48. 7.8.5 Vetoquinol Recent Developments
  49. 7.9 Virbac
  50. 7.9.1 Virbac Company Information
  51. 7.9.2 Virbac Business Overview
  52. 7.9.3 Virbac Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Virbac Veterinary Medicines and Vaccines Product Portfolio
  54. 7.9.5 Virbac Recent Developments
  55. 7.10 Zoetis
  56. 7.10.1 Zoetis Company Information
  57. 7.10.2 Zoetis Business Overview
  58. 7.10.3 Zoetis Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Zoetis Veterinary Medicines and Vaccines Product Portfolio
  60. 7.10.5 Zoetis Recent Developments
  61. 7.11 Bayer Animal Health
  62. 7.11.1 Bayer Animal Health Company Information
  63. 7.11.2 Bayer Animal Health Business Overview
  64. 7.11.3 Bayer Animal Health Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Bayer Animal Health Veterinary Medicines and Vaccines Product Portfolio
  66. 7.11.5 Bayer Animal Health Recent Developments
  67. 7.12 Merck Animal Health
  68. 7.12.1 Merck Animal Health Company Information
  69. 7.12.2 Merck Animal Health Business Overview
  70. 7.12.3 Merck Animal Health Veterinary Medicines and Vaccines Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Merck Animal Health Veterinary Medicines and Vaccines Product Portfolio
  72. 7.12.5 Merck Animal Health Recent Developments
8 North America
  1. 8.1 North America Veterinary Medicines and Vaccines Revenue (2021-2032)
  2. 8.2 North America Veterinary Medicines and Vaccines Revenue by Type (2021-2032)
  3. 8.2.1 North America Veterinary Medicines and Vaccines Revenue by Type (2021-2026)
  4. 8.2.2 North America Veterinary Medicines and Vaccines Revenue by Type (2027-2032)
  5. 8.3 North America Veterinary Medicines and Vaccines Revenue Share by Type (2021-2032)
  6. 8.4 North America Veterinary Medicines and Vaccines Revenue by Application (2021-2032)
  7. 8.4.1 North America Veterinary Medicines and Vaccines Revenue by Application (2021-2026)
  8. 8.4.2 North America Veterinary Medicines and Vaccines Revenue by Application (2027-2032)
  9. 8.5 North America Veterinary Medicines and Vaccines Revenue Share by Application (2021-2032)
  10. 8.6 North America Veterinary Medicines and Vaccines Revenue by Country
  11. 8.6.1 North America Veterinary Medicines and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Veterinary Medicines and Vaccines Revenue by Country (2021-2026)
  13. 8.6.3 North America Veterinary Medicines and Vaccines Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Veterinary Medicines and Vaccines Revenue (2021-2032)
  2. 9.2 Europe Veterinary Medicines and Vaccines Revenue by Type (2021-2032)
  3. 9.2.1 Europe Veterinary Medicines and Vaccines Revenue by Type (2021-2026)
  4. 9.2.2 Europe Veterinary Medicines and Vaccines Revenue by Type (2027-2032)
  5. 9.3 Europe Veterinary Medicines and Vaccines Revenue Share by Type (2021-2032)
  6. 9.4 Europe Veterinary Medicines and Vaccines Revenue by Application (2021-2032)
  7. 9.4.1 Europe Veterinary Medicines and Vaccines Revenue by Application (2021-2026)
  8. 9.4.2 Europe Veterinary Medicines and Vaccines Revenue by Application (2027-2032)
  9. 9.5 Europe Veterinary Medicines and Vaccines Revenue Share by Application (2021-2032)
  10. 9.6 Europe Veterinary Medicines and Vaccines Revenue by Country
  11. 9.6.1 Europe Veterinary Medicines and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Veterinary Medicines and Vaccines Revenue by Country (2021-2026)
  13. 9.6.3 Europe Veterinary Medicines and Vaccines Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Veterinary Medicines and Vaccines Revenue (2021-2032)
  2. 10.2 China Veterinary Medicines and Vaccines Revenue by Type (2021-2032)
  3. 10.2.1 China Veterinary Medicines and Vaccines Revenue by Type (2021-2026)
  4. 10.2.2 China Veterinary Medicines and Vaccines Revenue by Type (2027-2032)
  5. 10.3 China Veterinary Medicines and Vaccines Revenue Share by Type (2021-2032)
  6. 10.4 China Veterinary Medicines and Vaccines Revenue by Application (2021-2032)
  7. 10.4.1 China Veterinary Medicines and Vaccines Revenue by Application (2021-2026)
  8. 10.4.2 China Veterinary Medicines and Vaccines Revenue by Application (2027-2032)
  9. 10.5 China Veterinary Medicines and Vaccines Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Veterinary Medicines and Vaccines Revenue (2021-2032)
  2. 11.2 Asia Veterinary Medicines and Vaccines Revenue by Type (2021-2032)
  3. 11.2.1 Asia Veterinary Medicines and Vaccines Revenue by Type (2021-2026)
  4. 11.2.2 Asia Veterinary Medicines and Vaccines Revenue by Type (2027-2032)
  5. 11.3 Asia Veterinary Medicines and Vaccines Revenue Share by Type (2021-2032)
  6. 11.4 Asia Veterinary Medicines and Vaccines Revenue by Application (2021-2032)
  7. 11.4.1 Asia Veterinary Medicines and Vaccines Revenue by Application (2021-2026)
  8. 11.4.2 Asia Veterinary Medicines and Vaccines Revenue by Application (2027-2032)
  9. 11.5 Asia Veterinary Medicines and Vaccines Revenue Share by Application (2021-2032)
  10. 11.6 Asia Veterinary Medicines and Vaccines Revenue by Country
  11. 11.6.1 Asia Veterinary Medicines and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Veterinary Medicines and Vaccines Revenue by Country (2021-2026)
  13. 11.6.3 Asia Veterinary Medicines and Vaccines Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Veterinary Medicines and Vaccines Revenue (2021-2032)
  2. 12.2 SAMEA Veterinary Medicines and Vaccines Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Veterinary Medicines and Vaccines Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Veterinary Medicines and Vaccines Revenue by Type (2027-2032)
  5. 12.3 SAMEA Veterinary Medicines and Vaccines Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Veterinary Medicines and Vaccines Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Veterinary Medicines and Vaccines Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Veterinary Medicines and Vaccines Revenue by Application (2027-2032)
  9. 12.5 SAMEA Veterinary Medicines and Vaccines Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Veterinary Medicines and Vaccines Revenue by Country
  11. 12.6.1 SAMEA Veterinary Medicines and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Veterinary Medicines and Vaccines Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Veterinary Medicines and Vaccines Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst